Expert consensus on clinical practice of EGFR exon20 insertion detection in non-small cell lung cancer in China (2024 edition)
Article in Chinese Journal of Oncology (March 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
First report of furmonertinib as a first-line treatment in advanced lung adenocarcinoma patients harboring EGFR exon 20 insertion mutations after the kinase domain αC-helix: Two case reports and a literature review
Article in Medicine (December 2023)
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK-029A in Treatment-Naive Patients With Advanced NSCLC Harboring EGFR Exon 20 Insertion Mutations: A Phase 1 Trial
Article in Journal of Thoracic Oncology (September 2023)